Read + Share
Amedeo Smart
Independent Medical Education
. Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2. Neurology 2023 Apr 4:10.1212/WNL.0000000000207168.PMID: 37015824
Email
LinkedIn
Facebook
Twitter
Privacy Policy